Literature DB >> 31734651

The bone hormones and their potential effects on glucose and energy metabolism.

Daniel Addai1, Jacqueline Zarkos1, Anna Tolekova1.   

Abstract

The bones form the framework of our body. We know that bones protect our vital organs, regulate calcium and phosphorous homeostasis, and function as a site of erythropoiesis. More recently, however, the identification of bone hormones has allowed us to envision bones as endocrine organs too. Within the last few years, the bone hormones osteocalcin and lipocalin 2 have been implicated with glucose and energy metabolism. We systematically reviewed articles surrounding this subject and found a clear relationship between the osteocalcin levels and glucose tolerance and insulin sensitivity. We also found that many journals have shown the detrimental effects of an absences of lipocalin 2 from adipocytes. As osteocalcin administration to mice showed decreased blood glucose levels and promoted glucose tolerance and insulin sensitivity. Future studies could perhaps explore the use of osteocalcin as a supplement for type 2 diabetes.

Entities:  

Keywords:  energy metabolism; glucose; insulin; lipocalin 2; osteocalcin

Mesh:

Substances:

Year:  2019        PMID: 31734651     DOI: 10.2478/enr-2019-0027

Source DB:  PubMed          Journal:  Endocr Regul        ISSN: 1210-0668


  3 in total

1.  Spirulina Enhances Bone Modeling in Growing Male Rats by Regulating Growth-Related Hormones.

Authors:  Jin Ah Cho; Seong Yeon Baek; Sun Hee Cheong; Mee Ree Kim
Journal:  Nutrients       Date:  2020-04-24       Impact factor: 5.717

Review 2.  Endocrine Disruptors as a New Etiologic Factor of Bone Tissue Diseases (Review).

Authors:  N V Yaglova; V V Yaglov
Journal:  Sovrem Tekhnologii Med       Date:  2021-01-01

3.  Bone Marrow Metabolism Is Impaired in Insulin Resistance and Improves After Exercise Training.

Authors:  Ronja Ojala; Kumail K Motiani; Kaisa K Ivaska; Milja Arponen; Jari-Joonas Eskelinen; Kirsi A Virtanen; Eliisa Löyttyniemi; Marja A Heiskanen; Mueez U-Din; Pirjo Nuutila; Kari K Kalliokoski; Jarna C Hannukainen
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.